Sarcomas often return after surgery because surgeons can't see where tumor ends and healthy tissue begins. Our Helmholtz-funded project combines an optical tracer visible through infrared imaging with targeted alpha radiation therapy to achieve complete tumor removal even at the single-cell level. 

The clinical goal: Fewer recurrences, shorter treatments, and better outcomes for patients otherwise facing years of harsh but ineffective therapy. 

Contact

  • Oliver Bruns - NCT Dresden
  • Oliver Plettenburg - Helmholtz Munich
  • Sven Stadlbauer - HZDR
  • Matthias Miederer - NCT